Literature DB >> 26859630

Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?

Mary A Fristad1, Hannah Wolfson1, Guillermo Perez Algorta2, Eric A Youngstrom3, L Eugene Arnold1, Boris Birmaher4, Sarah Horwitz5, David Axelson1,6, Robert A Kowatch1,6, Robert L Findling7.   

Abstract

OBJECTIVE: The purpose of this study was to examine similarities and differences between disruptive mood dysregulation disorder (DMDD) and bipolar disorder not otherwise specified (BP-NOS) in baseline sociodemographic and clinical characteristics and 36 month course of irritability in children 6-12.9 years of age.
METHODS: A total of 140 children with DMDD and 77 children with BP-NOS from the Longitudinal Assessment of Manic Symptoms cohort were assessed at baseline, then reassessed every 6 months for 36 months.
RESULTS: Groups were similar on most sociodemographic and baseline clinical variables other than most unfiltered (i.e., interviewer-rated regardless of occurrence during a mood episode) Young Mania Rating Scale (YMRS) and parent-reported General Behavior Inventory-10 Item Mania (PGBI-10M) items. Children with DMDD received lower scores on every item (including irritability) except impaired insight; differences were significant except for sexual interest and disruptive-aggressive behavior. Children with DMDD received lower scores on eight of 10 PGBI-10M items, the other two items rated irritability. Youth with DMDD were significantly less likely to have a biological parent with a bipolar diagnosis than were youth with BP-NOS. Children with DMDD were more likely to be male and older than children with BP-NOS, both small effect sizes, but had nearly double the rate of disruptive behavior disorders (large effect). Caregiver ratings of irritability based on the Child and Adolescent Symptom Inventory-4R (CASI-4R) were comparable at baseline; the DMDD group had a small but significantly steeper decline in scores over 36 months relative to the BP-NOS group (b = -0.24, SE = 0.12, 95% CI -0.48 to -0.0004). Trajectories for both groups were fairly stable, in the midrange of possible scores.
CONCLUSIONS: In a sample selected for elevated symptoms of mania, twice as many children were diagnosed with DMDD than with BP-NOS. Children with DMDD and BP-NOS are similar on most characteristics other than manic symptoms, per se, and parental history of bipolar disorder. Chronic irritability is common in both groups. Comprehensive evaluations are needed to diagnose appropriately. Clinicians should not assume that chronic irritability leads exclusively to a DMDD diagnosis.

Entities:  

Mesh:

Year:  2016        PMID: 26859630      PMCID: PMC4800383          DOI: 10.1089/cap.2015.0062

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  33 in total

Review 1.  The importance of cognitive errors in diagnosis and strategies to minimize them.

Authors:  Pat Croskerry
Journal:  Acad Med       Date:  2003-08       Impact factor: 6.893

2.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

3.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

4.  The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics.

Authors:  B Birmaher; S Khetarpal; D Brent; M Cully; L Balach; J Kaufman; S M Neer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-04       Impact factor: 8.829

5.  Preliminary studies of the reliability and validity of the children's depression rating scale.

Authors:  E O Poznanski; J A Grossman; Y Buchsbaum; M Banegas; L Freeman; R Gibbons
Journal:  J Am Acad Child Psychiatry       Date:  1984-03

6.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

7.  Brief screening for family psychiatric history: the family history screen.

Authors:  M M Weissman; P Wickramaratne; P Adams; S Wolk; H Verdeli; M Olfson
Journal:  Arch Gen Psychiatry       Date:  2000-07

Review 8.  Defining clinical phenotypes of juvenile mania.

Authors:  Ellen Leibenluft; Dennis S Charney; Kenneth E Towbin; Robinder K Bhangoo; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

9.  A children's global assessment scale (CGAS).

Authors:  D Shaffer; M S Gould; J Brasic; P Ambrosini; P Fisher; H Bird; S Aluwahlia
Journal:  Arch Gen Psychiatry       Date:  1983-11

10.  Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children.

Authors:  Andrea M Yee; Guillermo Perez Algorta; Eric A Youngstrom; Robert L Findling; Boris Birmaher; Mary A Fristad
Journal:  J Clin Child Adolesc Psychol       Date:  2014-06-02
View more
  10 in total

1.  A multimethod screening approach for pediatric depression onset: An incremental validity study.

Authors:  Joseph R Cohen; Hena Thakur; Katie L Burkhouse; Brandon E Gibb
Journal:  J Consult Clin Psychol       Date:  2018-12-20

2.  The Clinician Affective Reactivity Index: Validity and Reliability of a Clinician-Rated Assessment of Irritability.

Authors:  Simone P Haller; Katharina Kircanski; Argyris Stringaris; Michal Clayton; Hong Bui; Courtney Agorsor; Sofia I Cardenas; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman
Journal:  Behav Ther       Date:  2019-11-27

Review 3.  Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Authors:  Kazuyoshi Ogasawara; Yukako Nakamura; Hiroyuki Kimura; Branko Aleksic; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2017-12-23       Impact factor: 3.575

Review 4.  Diagnostic instruments for the assessment of disruptive mood dysregulation disorder: a systematic review of the literature.

Authors:  Ines Mürner-Lavanchy; Michael Kaess; Julian Koenig
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-07-07       Impact factor: 4.785

Review 5.  How and Why Are Irritability and Depression Linked?

Authors:  Pablo Vidal-Ribas; Argyris Stringaris
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2021-04

6.  Is Irritability a Top Problem in Youth Mental Health Care? A Multi-informant, Multi-method Investigation.

Authors:  Spencer C Evans; Katherine A Corteselli; Audrey Edelman; Hannah Scott; John R Weisz
Journal:  Child Psychiatry Hum Dev       Date:  2022-01-22

Review 7.  The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.

Authors:  Benjamin I Goldstein; Boris Birmaher; Gabrielle A Carlson; Melissa P DelBello; Robert L Findling; Mary Fristad; Robert A Kowatch; David J Miklowitz; Fabiano G Nery; Guillermo Perez-Algorta; Anna Van Meter; Cristian P Zeni; Christoph U Correll; Hyo-Won Kim; Janet Wozniak; Kiki D Chang; Manon Hillegers; Eric A Youngstrom
Journal:  Bipolar Disord       Date:  2017-09-25       Impact factor: 6.744

8.  Long-Term Comorbid Neuropsychiatric Sequelae of Hypoxia at Birth.

Authors:  Christina Mercogliano; Karuna Poddar
Journal:  Cureus       Date:  2021-01-13

9.  Development and Initial Validation of the Disruptive Mood Dysregulation Disorder Questionnaire Among Adolescents From Clinic Settings.

Authors:  Assia Boudjerida; Réal Labelle; Lise Bergeron; Claude Berthiaume; Jean-Marc Guilé; Jean-Jacques Breton
Journal:  Front Psychiatry       Date:  2022-02-17       Impact factor: 4.157

Review 10.  Disruptive mood dysregulation disorder: current insights.

Authors:  Raman Baweja; Susan D Mayes; Usman Hameed; James G Waxmonsky
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-24       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.